Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

張俊欽 (Chun-Chin Chang)

張俊欽(Chun-Chin Chang)圖 Return Appointment First Appointment

[Profile]

  • Education
    • 博士, 醫學; 鹿特丹伊拉斯姆大學, 鹿特丹, 荷蘭,
    • 博士, 臨床醫學研究所; 陽明交通大學, 臺北巿,
    • 國立陽明大學醫學士,
  • Career and Experience
    Current Positions：
    • - Now, 主治醫師, 內科部心臟內科, 臺北榮民總醫院,
    • - Now, Attending physician, Division of Cardiology, Taipei Veterans General Hospital, Taipei,
    • 2022- Now, 助理教授, 醫學院醫學系, 國立陽明交通大學,
    Experiences：
    • - , 主治醫師, 心臟內科, 臺北榮民總醫院桃園分院,
    • - , EuroIntervention local associate editor,
    • - , 進修醫師, 心導管室, 日本神戶大學附設醫院 ,
    • - , 總醫師, 內科部心臟內科, 臺北榮民總醫院,
    • - , 住院醫師, 內科部, 臺北榮民總醫院,
  • Medical Expertise
    1. 成人心臟內科
    2. 冠狀動脈心導管介入治療
    3. 瓣膜性心臟病
    4. 經導管瓣膜介入治療
    5. 周邊血管介入治療
  • License
    中華民國內科專科醫師 中華民國心臟專科醫師 中華民國心臟血管介入專科醫師 中華民國重症醫學專科醫師 中華民國心臟專科指導醫師

[Publications]

  1. Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov  I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S,  Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW; TALENT trial investigators.  Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.  Lancet.  2019;393(10175):987-997.
  2. Chang CC, Kogame N, Onuma Y, Byrne RA, Capodanno D, Windecker S, Morel MA, Cutlip DE, Krucoff MW, Stone GW,  Lansky AJ, Mehran R, Spitzer E, Fraser  AG, Baumbach A, Serruys PW. Defining Device Success for Percutaneous Coronary  Intervention Trials: A Position Statement from the European Association of    Percutaneous Cardiovascular Interventions of the European Society of Cardiology. EuroIntervention. 2019; pii: EIJ-D-19-00552
  3. van Geuns RJ, Chang CC, McEntegart MB, Merkulov E, Kretov E, Lesiak M, O'Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG. Bioabsorbable-polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable-polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomized trial. EuroIntervention. 2022;17(18):1467-1476.
  4. Chang CC, Veen KM, Hahn RT, Bogers AJJC, Latib A, Oei FBS, Abdelghani M,  Modolo R, Ho SY,  Abdel-Wahab M, Fattouch K, Bosmans J, Caliskan K, Taramasso M, Serruys PW, Bax JJ, van Mieghem NMDA,  Takkenberg JJM, Lurz P, Modine T, Soliman O. Uncertainties and challenges in surgical and transcatheter tricuspid  valve  therapy: a state-of-the-art expert review.  Eur Heart J. 2019; pii: ehz614.
  5. Chang CC, Lee YH, Chuang MJ, Hsueh CH, Lu YW, Tsai YL, Chou RH, Wu CH, Lu TM, Huang PH, Lin SJ, van Geuns RJ. Agreement Between Invasive Wire-based and Angiography-Based Vessel Fractional Flow Reserve Assessment on Intermediate Coronary Stenoses. Front Cardiovasc Med. 2021;8:707454.

限於篇幅,以上謹為代表著作

回到最上